Eli Lilly Launches Half-Priced Insulin in Response to Criticism Over Cost

Drug Industry Daily
A A
Eli Lilly’s lower-cost generic of its blockbuster insulin drug Humalog (insulin lispro) hit pharmacies on Wednesday following months of heat from both Congress and the White House over high insulin drug prices.

To View This Article:

Login

Subscribe To Drug Industry Daily